NCT01578837View on ClinicalTrials.gov

Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Diabetes Mellitus Type 2Hypertension
Interventions
DIETARY_SUPPLEMENT

Ginseng

2.25g of encapsulated ginseng (1.5g American Ginseng and 0.75g Rg3-enriched Korean Red Ginseng)will be administered in 6 identical capsules, 2 capsules with each meal (total 6 capsules per day).

DIETARY_SUPPLEMENT

Wheat Bran

2.25g of encapsulated 100% natural wheat bran will be administered in 6 identical capsules, 2 capsules with each meal (total 6 capsules per day).

Trial Locations (2)

10000

Clinical Centre Vuk Vrhovac, Zagreb

M5B 1W8

Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Diabetes Association

OTHER

lead

Unity Health Toronto

OTHER

NCT01578837 - Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes | Biotech Hunter | Biotech Hunter